Sanofi Pasteur Begins Selling Merck's HPV Vaccine Gardasil In Six E.U. Countries
Main Category: Women's Health / GynecologyAlso Included In: Pediatrics / Children's Health; Pharma Industry / Biotech Industry; Cervical Cancer / HPV Vaccine
Article Date: 20 Oct 2006 - 6:00 PDT
| Patient / Public: | ![]() |
5 (2 votes) |
| Healthcare Prof: | ![]() |
Sanofi Pasteur, a joint company of Merck and Sanofi-Aventis, recently began selling Merck's human papillomavirus vaccine Gardasil in Austria, Finland, Germany, Ireland, Sweden and the United Kingdom, Reuters reports (Reuters, 10/17). The European Commission late last month approved Gardasil for sale and marketing in the European Union. According to Merck, the vaccine in clinical trials has been shown to be 100% effective in preventing HPV infection with strains 16 and 18, which together cause about 70% of cervical cancer cases, in women who do not already have the virus, and about 99% effective in preventing HPV strains 6 and 11, which together with strains 16 and 18 cause about 90% of genital wart cases. Gardasil also protects against vaginal and vulvar cancers, two other gynecological cancers that are linked to HPV, according to a study presented in June at a meeting of the American Society of Clinical Oncology in Atlanta. In the U.K., the Joint Committee on Vaccination and Immunisation, an independent advisory committee for the U.K. Department of Health, will decide if the vaccine will be covered by the National Health System (Kaiser Daily Women's Health Policy Report, 9/25). Sanofi Pasteur plans to launch sales of the vaccine in most E.U. countries by the end of 2006, but the vaccine will not be available in Italy, Greece or Spain until 2007. According to Reuters, Gardasil in the E.U. will cost between $565 and $753 depending on the country (Reuters, 10/17).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our women's health / gynecology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/54511.php>
APA
http://www.medicalnewstoday.com/releases/54511.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




